Louis A. Cannon, Founder and Senior Managing Director, Charlevoix, MI, United States — verified investor profile. See sector focus and contact routes.
Louis A. Cannon, MD, is the founder of BioStar Capital, a venture firm investing in early- and late-stage transformative medical technologies primarily in cardiology, orthopedics, and robotics. His distinctive thesis focuses on cardiovascular and orthopedic devices, including non-iterational innovations, developed swiftly by physicians to avoid bureaucratic delays in large medical device companies. Notable portfolio companies include Ellipse Technologies (sold to NuVasive Inc.) and TransMedics (co-invested with Kleiner Perkins). Cannon manages over $250 million in medical device assets and has sold eight of 13 companies founded under his model.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Charlevoix.
Investors like Louis A. Cannon · Full investor directory · Investor access · Company funding database